Treatment Plan Analysis of Tomotherapy versus VMAT in Locally Advanced Non-Small Cell Lung Cancer Radiotherapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20200724003

Enrollment

Unknown

Registered

2020-07-24

Start date

2017-08-07

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

locally advanced non&#45

Interventions

Tomotherapy technique,volumetric modulated arc therapy

Active Comparator Radiation,Active Comparator Radiation

Tomotherapy,VMAT

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: locally advanced non-small cell lung cancer received radiation therapy

Exclusion criteria

Exclusion criteria: Stage IV

Design outcomes

Primary

Measure	Time frame
PTV dose parameters, HI, CN, Organ at risk dose parameters after completion of planning WSR test	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactPitchayponne Klunklin

Chiangmai University

pklunklin@gmail.com+66846092813

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Treatment Plan Analysis of Tomotherapy versus VMAT in Locally Advanced Non&#45;Small Cell Lung Cancer Radiotherapy